Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Clinical trial NCT06773936 · ENROLLING_BY_INVITATION

Trial details

NCT number

NCT06773936

Sponsor

SWOG Cancer Research Network

Status

ENROLLING_BY_INVITATION

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-04-13

Primary completion

2029-05-01

Enrollment

55

View on ClinicalTrials.gov